Introduction:
The prenatal diagnosis of congenital heart defects has been well established. However, even with an a n t e n a t a l d i a g n o s i s , some neonates, despite planned delivery in the tertiary center and proper perinatal management, would not survive due to many reasons, among them, pulmonary hypertension.
It is well known that prenatal restrictive foramen ovale, and or ductus arteriosus constriction or reversal flow in pulmonary veins may jeopardise the postnatal outcome. The goal of our research was to observe if there are any other prenatal echocardiographic features that may increase the risk of neonatal pulmonary hypertension and adverse outcome in fetuses with congenital heart defects.
The second part of the analysis was dedicated to the subgroup that had echocardiographic examinations in the Department of Prenatal Cardiology in our Hospital before delivery (Fig. 3) . Out of 83 patients, 43 did not have prenatal echocardiography, and 40 underwent fetal echocardiography in our center.
Fetal echocardiograms were performed transabdominally using Voluson E8, Voluson 730 (GE Healthcare Ultrasound) or Philips Medical HDI. All examinations had digital storage.
All prenatal echocardiograms were reviewed from earlier recordings in order to double check the fetal heart size, FO size (the diameter of FO was measured between the superior and inferior limbs of the FO, where the FO flap was at its maximum leftward excursion during the cardiac cycle, from a four-chamber orientation of the fetal heart, with the plane of imaging perpendicular to the plane of the atrial septum), the diameter of pulmonary artery (PA), and aortic artery (Ao) in mediastinum where they were both visible at the same time, the diameter of PV branches, and, if available, the pattern and velocity of flow across the FO, and the pattern flow of the pulmonary veins at the left atrial junction. Tracings were obtained with the sample volume as parallel to the direction of blood flow as possible.
It was a retrospective evaluation of the medical records from the computer database and second evaluation of frozen frames and cine loop movies from the last echo exam before delivery to answer the question: is it possible to suggest neonatal "late" pulmonary hypertension? Moreover, based on what prenatal echocardiographic findings?
Materials and Methods
We retrospectively identified all neonates with CHD who died in our Institute and underwent autopsy examination in years 2010 -2015, and identified those who had The measurements of the pulmonary artery (in mm) and right pulmonary artery from the prenatal group were superimposed on normograms from Ruano 6 .
Next step, the measurements of the pulmonary artery and aortic artery and pulmonary/aortic ratio, were compared in study group and our own normal control group (n= 134 fetuses) and in the group of fetuses with HLHS (n= 14), who after surgery were in good condition and were discharged from the hospital.
For statistical analysis Shapiro-Wilk test was used to check if there was normal distribution and t-Student test to compare the 3 groups. Cut off value of 0,05 was accepted.
The fetal PV flow pattern was considered normal in the event of forward flow in ventricular systole and diastole, questionable with cessation of flow or small a-wave reversal during atrial systole and abnormal in the case of reversal of the a-wave.
The time gap between last echo and time of delivery, fetal karyotype, type of delivery, birth weight, Apgar score and clinical outcome, were also evaluated.
results
Fetal echocardiography was performed min once, max 7 times per fetus (mean 2,5), with total 94 examinations in 40 cases in our referral center. The fetal echo measurements were analyzed from the last fetal echo before delivery.
In the prenatal group there were 25 cases of low-risk pregnancies and 15 cases of high risk pregnancies: 3x twins after IVF, 1 x twin spontaneous gestation after demise of the co-twin in 1 st trimester, maternal infection in 1 trimester (4x), previous miscarriages (4x), maternal epi (1), maternal cholestasis (1) and 1 prenatal valvuloplasty of aortic valve at the 28th week of gestation.
In the prenatal group, in 35 fetuses NT were measured in 1 st trimester and were 1,9 +/0,9 mm. Abnormal NT was present in two fetuses: 4,5 and 5 mm (first one with 45,XO the other one with SLO Syndrome: 46 XY and truncus arteriosus, female genitalia, syndactyly, microcephaly). In the other nine fetuses that underwent amniocentesis, normal karyotype and no genetic syndromes were suspected.
Fetal heart defects in prenatal subgroup were diagnosed at mean 23 +/-4 wks of gestation, and the last echocardiography exam was performed at mean 34,9 +/-3 wks ( In the prenatal group, extracardiac malformations and anomalies were present in 14 fetuses such as single umbilical artery 1 x, pyelectasis 1 x, esophageal atresia 1 x, situs inversus 1x, maternal myoma (8 cm) 1x, hydrops testis 1 x and in 6 fetuses placental thickness > 6 cm.
All fetuses based on the last echocardiographic exam were without congestive heart failure (CVPS 9,2+/0,7). The mean birth weight was 2955+/-469g and mean Apgar score 8+/-1,5.
All but one neonate did not require respiratory support in the first day after delivery (in one case CPAP was introduced). All neonates from the prenatal group were delivered in our tertiary center, with known prenatal diagnosis, which was confirmed by neonatal echo, they received prostin in ductal dependent circulations, all were in good clinical condition before and after delivery. All of them died before discharge from the hospital and in all of them upon autopsy in addition to the confirmation of prenatal diagnosis pulmonary hypertension was established based on histopathology evaluation of the lung tissue (HR and ECz).
Mean time of neonatal cardiac surgery in the prenatal group was 15 days +/8 days, and the mean time of death was 27 days +/ 17 days (Table 2 ).
In five of the presented cases pulmonary hypertension was suspected based on clinical evaluation ("pulmonary hypertension" mentioned in final clinical diagnosis in medical records before autopsy).
There were statistical differences between PA/Ao ratio at 39 weeks of gestation in fetuses in the control group and fetuses in study group ("pulmonary hypertension" after birth) (p=0,044) There were statistical differences between PA/AO ratio at 39 weeks of gestation in fetuses in study group (with "pulmonary hypertension" after birth) and fetuses with HLHS, alive & well after first surgery (p=0,027) There were no differences between PA/AO ratio at 39 weeks of gestation in fetuses in control group and fetuses with HLHS, alive & well after first surgery With the progress in prenatal cardiology, more fetuses undergo transfer in utero to tertiary centers, and there is more evidence that prenatal diagnosis may improve perinatal outcome in some congenital heart defects such as HLHS and TGA 7, 8, 9, 10, 11, 12, 13, 14 . In tertiary center not only prenatal diagnosis is usually confirmed but based on foramen ovale echo assessment and pulmonary vein flow in 3 rd trimester or just before delivery the subgroup of critical heart defects may be subtracted for further speed of perinatal cardiological "make up", especially in cases of restriction of the foramen ovale or prenatal constriction of ductus arteriosus, as known risk factors 8 .
However still despite proper prenatal care, selected time and place of delivery, proper postnatal management and neonatal cardiac surgery some neonates die (even without foramen ovale restriction and/ or ductus arteriosus prenatal constriction) despite all of the efforts current medicine may offer them.
One of the causes of poor outcome is pulmonary hypertension, which is not always clinically evident and, therefore, difficult for early management, assuming as suggested by Wagenvoort 15 that it could be reversible at least at some stage of the disease.
Our data has shown that at our institution pulmonary hypertension was a leading cause of neonatal death, (10-20 deaths per year) despite prenatal in utero transfer, proper perinatal care, cardiology service and cardiac surgery within the same institution (Fig,1, 2 ).
So far, neonatal pulmonary hypertension was discussed mainly in prenatally detected TGA 9 , HLHS 16 and congenital obstruction of pulmonary venous return 17 . However, our results and data from pediatric cardiology has shown that this anomaly may be present also quite often in other heart malformations such as truncus arteriosus as well as in other congenital heart defects.
As fetal circulation changes in 2 nd and 3 rd -trimester restriction of the foramen ovale is usually picked up very late in gestation 18, 19 . It was interesting to see in our results of pulmonary artery and RPA measurements superimposed on normograms from Ruano, that it was obvious to see pulmonary artery dilatation in a majority of cases without evidence of RPA dilatation. However these last measurements were less frequently available for analysis.
None of our neonates with prenatally detected and diagnosed CHD had cyanosis or heart failure, all of them received prostin infusion, only one of them required CPAP for the first 4 hours of life, which indicate that clinical deterioration was silent in the first hours and days after delivery.
Early prenatal suspicion of pulmonary hypertension in the case of congenital heart defect may allow to consider neonatal inhaled nitric oxide therapy 20, 21 . Alternatively, more precise genetic makeup in the future 22, 23 , or maybe better chosen time of cardiac surgery.
Limitations of this study: the lack of evaluation of characteristics of blood flow in the peripheral area of the lungs with color or power Doppler; lack of measurements of RPA and LPA in all cases, no application of the results in a subgroup of fetuses with truncus arteriosus
The strength of this study was: the highly selected data collected and prospectively analyzed fetal echocardiogram with complete follow-up from gestational age to postnatal follow-up and autopsy confirmation (without cases of termination of pregnancies).
ConClusions:
Pulmonary hypertension was a frequent cause of neonatal death among our series of congenital heart defects Dilatation of pulmonary artery in fetal echo just before delivery may be an important risk factor for poor neonatal outcome in case of congenital heart defect.
